3.9 Article

Reduced Frequencies and Heightened CD103 Expression among Virus-Induced CD8+ T Cells in the Respiratory Tract Airways of Vitamin A-Deficient Mice

Journal

CLINICAL AND VACCINE IMMUNOLOGY
Volume 19, Issue 5, Pages 757-765

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/CVI.05576-11

Keywords

-

Funding

  1. NIH NIAID [P01 AI054955, R01 AI088729, R01 AI076499]
  2. NIH NCI [P30-CA21765]
  3. American-Lebanese Syrian Associated Charities (ALSAC)

Ask authors/readers for more resources

Vitamin A deficiency (VAD) has profound effects on immune responses in the gut, but its effect on other mucosal responses is less well understood. Sendai virus (SeV) is a candidate human parainfluenza virus type 1 (hPIV-1) vaccine and a candidate vaccine vector for other respiratory viruses. A single intranasal dose of SeV elicits a protective immune response against hPIV-1 within days after vaccination. To define the effect of VAD on acute responses toward SeV, we monitored both antibodies and CD8(+) T cells in mice. On day 10 following SeV infection, there was a trend toward lower antibody activities in the nasal washes of VAD mice than in those of controls, while bronchoalveolar lavage (BAL) fluid and serum antibodies were not reduced. In contrast, there was a dramatic reduction of immunodominant CD8(+) T cell frequencies in the lower respiratory tract (LRT) airways of VAD animals. These T cells also showed unusually high CD103 (the alpha E subunit of alpha E beta 7) expression patterns. In both VAD and control mice, E-cadherin (the ligand for alpha E beta 7) was better expressed among epithelial cells lining the upper respiratory tract (URT) than in LRT airways. The results support a working hypothesis that the high CD103 expression among T cell populations in VAD mice alters mechanisms of T cell cross talk with URT and LRT epithelial cells, thereby inhibiting T cell migration and egress into the lower airway. Our data emphasize that the consequences of VAD are not limited to gut-resident cells and characterize VAD influences on an immune response to a respiratory virus vaccine.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.9
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available